Bayer Seeks FDA OK to Extend Mirena Duration to Six Years

Date : 10/21/2019 @ 3:13PM
Source : Dow Jones News
Stock : Bayer Aktiengesellschaft (PK) (BAYRY)
Quote : 19.46  -0.06 (-0.31%) @ 9:29PM

Bayer Seeks FDA OK to Extend Mirena Duration to Six Years

Bayer Aktiengesellschaft (PK) (USOTC:BAYRY)
Historical Stock Chart

1 Month : From Oct 2019 to Nov 2019

Click Here for more Bayer Aktiengesellschaft (PK) Charts.

By Colin Kellaher


Bayer AG (BAYN.XE) on Monday said it filed a supplemental new-drug application with the U.S. Food and Drug Administration seeking to extend the approved duration of its Mirena intrauterine device to six years.

The Leverkusen, Germany, chemical-and-pharmaceutical company said the request is based on results from a phase 3 extension trial evaluating the efficacy and safety of the contraceptive.

Mirena, which in 2000 became the first hormonal intrauterine device cleared for use in the U.S., is currently approved to prevent pregnancy for up to five years.


Write to Colin Kellaher at


(END) Dow Jones Newswires

October 21, 2019 10:58 ET (14:58 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

Latest BAYRY Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.